Literature DB >> 1246461

Therapeutic effects of glycine in isovaleric acidemia.

I Krieger, K Tanaka.   

Abstract

The effect of glycine administration on acute leucine loading (125 mg/kg) was tested in a patient with isovaleric acidemia. Serum isovaleric acid at 1-3/4 hr after the leucine loading alone was elevated to 5.60 mg/100 ml and urinary isovaleryglycine excretion was 9.90 mg/mg creatine/24 hr. Whe the same amount of leucine was given with glycine (250 mg/kg) serum isovaleric acid was only 0.93 mg/200 ml. Unfortunately, urine was collected for only 12 hr after the leucine-glycine loading. However, the amount of urinary isovaleryglycine was 26.2 mg/mg creatine in this period. In the following experiments in which a meal containing 80 mg leucine/kg was given, serum isovaleric acid was elevated to 1.14 and 1.01 mg/100 ml at 3 hr and 6 hr after the loading, respectively. How-ever, serum isovaleric acid was only 0.53 and 0.79 mg/100 ml at 3 and 6 hr, respectively, when the identical mean was given with 2 g glycine. The effect of long term glycine administration (250 mg/kg/24 hr) was also tested. It did not prevent two ketotic episodes which were caused by infections. However, the duration of clinical symptoms such as vomiting and a large anion gap in the acute episodes were much shorter with rectal glycine administration. The patient's linear growth and weight gain durin glycine administration was much better than that in the pretreatment period.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1246461     DOI: 10.1203/00006450-197601000-00005

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  12 in total

1.  L-carnitine and glycine therapy in isovaleric acidaemia.

Authors:  R A Chalmers; C de Sousa; B M Tracey; T E Stacey; C Weaver; D Bradley
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

2.  Two sisters with isovaleric acidaemia, multiple attacks of ketoacidosis and normal development.

Authors:  M Duran; F J van Sprang; J G Drewes; L Bruinvis; D Ketting; S K Wadman
Journal:  Eur J Pediatr       Date:  1979-06-28       Impact factor: 3.183

Review 3.  Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity.

Authors:  Jerry Vockley; Regina Ensenauer
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

4.  Clinical variability of isovaleric acidemia in a genetically homogeneous population.

Authors:  M Dercksen; M Duran; L Ijlst; L J Mienie; C J Reinecke; J P N Ruiter; H R Waterham; R J A Wanders
Journal:  J Inherit Metab Dis       Date:  2012-02-17       Impact factor: 4.982

5.  Characterization of variants of uncertain significance in isovaleryl-CoA dehydrogenase identified through newborn screening: An approach for faster analysis.

Authors:  Olivia M D'Annibale; Erik A Koppes; Ahmad N Alodaib; Catherine Kochersperger; Anuradha Karunanidhi; Al-Walid Mohsen; Jerry Vockley
Journal:  Mol Genet Metab       Date:  2021-08-30       Impact factor: 4.204

6.  Glycine and L-carnitine therapy in 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  S L Rutledge; G T Berry; C A Stanley; J L van Hove; D Millington
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Hudson memorial lecture. Neonatal management of organic acidurias. Clinical update.

Authors:  J M Saudubray; H Ogier; C Charpentier; E Depondt; F X Coudé; A Munnich; G Mitchell; F Rey; J Rey; J Frézal
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Complementation studies of isovaleric acidemia and glutaric aciduria type II using cultured skin fibroblasts.

Authors:  B Dubiel; C Dabrowski; R Wetts; K Tanaka
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  L-carnitine therapy in isovaleric acidemia.

Authors:  C R Roe; D S Millington; D A Maltby; S G Kahler; T P Bohan
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  The response to L-carnitine and glycine therapy in isovaleric acidaemia.

Authors:  C de Sousa; R A Chalmers; T E Stacey; B M Tracey; C M Weaver; D Bradley
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.